188 related articles for article (PubMed ID: 25026997)
1. The novel immunotherapeutic molecule T11TS modulates glioma-induced changes of key components of the immunological synapse in favor of T cell activation and glioma abrogation.
Chaudhuri S; Singh MK; Bhattacharya D; Acharya S; Chatterjee S; Kumar P; Bhattacharjee P; Basu AK; Sa G; Das T; Ghosh TK; Chaudhuri S
J Neurooncol; 2014 Oct; 120(1):19-31. PubMed ID: 25026997
[TBL] [Abstract][Full Text] [Related]
2. CD2-SLFA3/T11TS interaction facilitates immune activation and glioma regression by apoptosis.
Sarkar S; Ghosh A; Mukherjee J; Chaudhuri S; Chaudhuri S
Cancer Biol Ther; 2004 Nov; 3(11):1121-8. PubMed ID: 15467439
[TBL] [Abstract][Full Text] [Related]
3. Disease relevance of T11TS-induced T-cell signal transduction through the CD2-mediated calcineurin-NFAT pathway: Perspectives in glioma immunotherapy.
Chaudhuri S; Bhattacharya D; Singh MK; Moitra S; Ronsard L; Ghosh TK; Chaudhuri S
Mol Immunol; 2015 Oct; 67(2 Pt B):256-64. PubMed ID: 26105805
[TBL] [Abstract][Full Text] [Related]
4. T11TS immunotherapy repairs PI3K-AKT signaling in T-cells: Clues toward enhanced T-cell survival in rat glioma model.
Chaudhuri S; Singh MK; Bhattacharya D; Datta A; Hazra I; Mondal S; Faruk Sk Md O; Ronsard L; Ghosh TK; Chaudhuri S
J Cell Physiol; 2018 Feb; 233(2):759-770. PubMed ID: 28608562
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapeutic effects of T11TS/S-LFA3 against nitrosocompound mediated neural genotoxicity.
Mukherjee J; Sarkar S; Ghosh A; Duttagupta AK; Chaudhuri S; Chaudhuri S
Toxicol Lett; 2004 May; 150(3):239-57. PubMed ID: 15110076
[TBL] [Abstract][Full Text] [Related]
6. CD58 Immunobiology at a Glance.
Zhang Y; Liu Q; Yang S; Liao Q
Front Immunol; 2021; 12():705260. PubMed ID: 34168659
[TBL] [Abstract][Full Text] [Related]
7. Documentation of immune profile of microglia through cell surface marker study in glioma model primed by a novel cell surface glycopeptide T11TS/SLFA-3.
Begum Z; Ghosh A; Sarkar S; Mukherjee J; Mazumdar M; Sarkar P; Chaudhuri S
Glycoconj J; 2004; 20(9):515-23. PubMed ID: 15454689
[TBL] [Abstract][Full Text] [Related]
8. T11TS impedes glioma angiogenesis by inhibiting VEGF signaling and pro-survival PI3K/Akt/eNOS pathway with concomitant upregulation of PTEN in brain endothelial cells.
Bhattacharya D; Singh MK; Chaudhuri S; Acharya S; Basu AK; Chaudhuri S
J Neurooncol; 2013 May; 113(1):13-25. PubMed ID: 23471571
[TBL] [Abstract][Full Text] [Related]
9. A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals.
Demetriou P; Abu-Shah E; Valvo S; McCuaig S; Mayya V; Kvalvaag A; Starkey T; Korobchevskaya K; Lee LYW; Friedrich M; Mann E; Kutuzov MA; Morotti M; Wietek N; Rada H; Yusuf S; Afrose J; Siokis A; ; Meyer-Hermann M; Ahmed AA; Depoil D; Dustin ML
Nat Immunol; 2020 Oct; 21(10):1232-1243. PubMed ID: 32929275
[TBL] [Abstract][Full Text] [Related]
10. CD2 Immunobiology.
Binder C; Cvetkovski F; Sellberg F; Berg S; Paternina Visbal H; Sachs DH; Berglund E; Berglund D
Front Immunol; 2020; 11():1090. PubMed ID: 32582179
[TBL] [Abstract][Full Text] [Related]
11. ENU administration causes genomic instability along with single nucleotide polymorphisms in p53 during gliomagenesis: T11TS administration demonstrated in vivo apoptosis of these genetically altered tumor cells.
Mukherjee J; Ghosh A; Ghosh A; Chaudhuri S
Cancer Biol Ther; 2006 Feb; 5(2):156-64. PubMed ID: 16357521
[TBL] [Abstract][Full Text] [Related]
12. The CD2-CD58 axis: A novel marker predicting poor prognosis in patients with low-grade gliomas and potential therapeutic approaches.
Wu M; Chen Y; Hua G; Chunhui L
Immun Inflamm Dis; 2023 Oct; 11(10):e1022. PubMed ID: 37904707
[TBL] [Abstract][Full Text] [Related]
13. T11 target structure induced modulations of the pro-inflammatory and anti-infammatorycytokine expressions in experimental animals for glioma abrogation.
Singh MK; Chaudhuri S; Bhattacharya D; Kumar P; Datta A; Chaudhuri S
Int Immunopharmacol; 2015 Feb; 24(2):198-207. PubMed ID: 25528475
[TBL] [Abstract][Full Text] [Related]
14. T11TS immunotherapy potentiates the repressed calcineurin-NFAT signalling pathway of T cells in Cryptococcus neoformans infected rats: a cue towards T-cell activation for antifungal immunity.
Omar Faruk SM; Hazra I; Mondal S; Datta A; Moitra S; Das PK; Mishra R; Chaudhuri S
J Appl Microbiol; 2020 Sep; 129(3):753-767. PubMed ID: 32145053
[TBL] [Abstract][Full Text] [Related]
15. T11TS repress gliomagenic apoptosis of bone marrow hematopoietic stem cells.
Mondal S; Hazra I; Datta A; Sk Md OF; Moitra S; Tripathi SK; Chaudhuri S
J Cell Physiol; 2018 Jan; 233(1):269-290. PubMed ID: 28233371
[TBL] [Abstract][Full Text] [Related]
16. T11TS Treatment Augments Apoptosis of Glioma Associated Brain Endothelial Cells, Hint Toward Anti-Angiogenic Action in Glioma.
Bhattacharya D; Singh MK; Chaudhuri S; Datta A; Chaudhuri S
J Cell Physiol; 2017 Mar; 232(3):526-539. PubMed ID: 27255231
[TBL] [Abstract][Full Text] [Related]
17. A multimeric form of soluble recombinant sheep LFA-3 (CD58) inhibits human T-cell proliferation.
Yamashita K; Parish CR; Warren HS; Harrison LC
Immunology; 1997 Sep; 92(1):39-44. PubMed ID: 9370922
[TBL] [Abstract][Full Text] [Related]
18. Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58.
Veldman J; Visser L; Huberts-Kregel M; Muller N; Hepkema B; van den Berg A; Diepstra A
Blood; 2020 Nov; 136(21):2437-2441. PubMed ID: 32589698
[TBL] [Abstract][Full Text] [Related]
19. The role of CD2/LFA-3 interaction in antigen- and mitogen-induced activation of human T cells.
Tiefenthaler G; Hünig T
Int Immunol; 1989; 1(2):169-75. PubMed ID: 2484882
[TBL] [Abstract][Full Text] [Related]
20. T11 target structure exerts effector function by activating immune cells in CNS against glioma where cytokine modulation provide favorable microenvironment.
Ghosh A; Bhattacharya M; Sarkar P; Acharya S; Chaudhuri S
Indian J Exp Biol; 2010 Sep; 48(9):879-88. PubMed ID: 21506495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]